Caffeine is protective in patients with non-alcoholic fatty liver disease.
about
Non-alcoholic fatty liver disease: what the clinician needs to know.Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemicAssociation between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysisOily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver diseaseNon-alcoholic fatty liver disease: what has changed in the treatment since the beginning?4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis.Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study.Coffee consumption and NAFLD: a community based study on 1223 subjects.The influence of roasting and additional processing on the content of bioactive components in special purpose coffees.Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable?Coffee and Liver DiseaseCoffee consumption and risk of hepatocellular carcinoma: a meta-analysis of eleven epidemiological studies.Autophagy and liver disease.Coffee and liver - long way to go.Pathophysiology of NASH: perspectives for a targeted treatment.Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease.Impact of coffee on liver diseases: a systematic review.Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection?Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets.Management of fatty liver disease with the metabolic syndrome.Hepatic steatosis and steatohepatitis: Are they really two distinct entities?A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives.Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.Short-term effect of caffeine on olfactory function in hyposmic patients.Coffee consumption protects against progression in liver cirrhosis and increases long-term survival after liver transplantation.Caffeine reduces hepatic lipid accumulation through regulation of lipogenesis and ER stress in zebrafish larvae.Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion.Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.Caffeine ameliorates high energy diet-induced hepatic steatosis: sirtuin 3 acts as a bridge in the lipid metabolism pathway.Role of diet and nutritional management in non-alcoholic fatty liver disease.Beneficial Role of Coffee and Caffeine in Neurodegenerative Diseases: A Minireview.Current concepts and management approaches in nonalcoholic fatty liver disease.New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
P2860
Q24563068-E7A44D05-DBA9-4755-BA5C-0FC46F6F1420Q24563381-5863C22E-8540-4467-8DB8-42E362BC1B40Q26771874-1645282B-2404-4457-9387-DA9C073F08C8Q26784396-883E4182-A242-4523-97A4-84F12A7784D1Q26829503-47C73878-4965-4187-A28C-0B946FE3B7A9Q30412771-81CE5051-7C5D-4DFC-93CA-756D0D81164BQ33568261-A0F7EC09-0F53-4AB4-B756-A14F60656926Q35127037-C1938C4C-4636-4331-A520-2F8DDF85D2ECQ35716963-41AB8F61-1014-4B39-A2E6-6C6A13046386Q35831047-790B7056-984A-4A71-AC35-F46DDF9F44B0Q36010939-5DCE9B45-7F4D-4F9F-B8DD-341468860ECBQ36781591-1F06F273-BDCC-4EE0-B119-FB772FD92850Q36886788-068D82BC-E163-46C5-A5BA-73A02ED632BDQ37122782-6C94C792-9761-4AA7-9706-1A3092A9759EQ37613245-E41EEA82-1BDD-4B27-A2BA-92FD4AD12E77Q37613528-D0F3EBB7-34B4-422D-B9F4-1E95E8CF8D80Q37699476-123C7021-32C1-4523-987F-117BAE3A9BB2Q38136292-28F10A6F-13A1-459A-B0EF-F3D06F703F58Q38150457-ACD877F0-5436-4825-B11B-139410A51A14Q38160516-B1A4E2A1-7D77-4871-A59E-5D766C6D7D96Q38160948-31A701AC-85D3-461E-ADAE-72CF02036C01Q38199130-D51B0506-B8FD-4378-96DA-23DFA1F70A8CQ38224490-84F0E62E-EDA1-4A78-A6E9-E6740223AD73Q38588143-4DCDC17E-7141-4101-A01D-24996684B2ECQ39113148-A673BE58-0E8B-4FCE-AA61-EF1E8975CF9AQ40131624-53AFEF63-15E1-44A1-95B1-FF187F902289Q40790044-CAA4FA0C-9EB9-4245-9392-C80F3D54B542Q40908516-B96C9EFD-22FA-418F-B050-F5B28D6B3DB2Q41395063-FC7EDC9D-5576-41BA-94C3-D3213DF655A4Q47880294-03243163-9683-413C-9A7C-CBE8E1EC9CB1Q48225600-F7B73BE1-239A-41D7-89D2-DC52C955B7D6Q50441886-535F5B05-5CE4-44E6-A089-3170D0F55393Q50468162-C3B87964-5F36-421E-A56D-AA8B9166B693Q54572410-5D39115C-6607-49DE-91CA-A6E6D150EC91Q55609866-01263B15-EB1A-410F-9EF3-3CF992B38868Q57114860-D9105BA6-657E-46CA-A76E-0467B37D92E4
P2860
Caffeine is protective in patients with non-alcoholic fatty liver disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Caffeine is protective in patients with non-alcoholic fatty liver disease.
@en
Caffeine is protective in patients with non-alcoholic fatty liver disease.
@nl
type
label
Caffeine is protective in patients with non-alcoholic fatty liver disease.
@en
Caffeine is protective in patients with non-alcoholic fatty liver disease.
@nl
prefLabel
Caffeine is protective in patients with non-alcoholic fatty liver disease.
@en
Caffeine is protective in patients with non-alcoholic fatty liver disease.
@nl
P2093
P2860
P1476
Caffeine is protective in patients with non-alcoholic fatty liver disease.
@en
P2093
A Birerdinc
L Pawloski
M Stepanova
Z M Younossi
P2860
P356
10.1111/J.1365-2036.2011.04916.X
P407
P577
2011-11-07T00:00:00Z